References
- Péanne R, De Lonlay P, Foulquier F, Kornak U, Lefeber DJ, Morava E, Pérez B, Seta N, Thiel C, Van Schaftingen E, et al. Congenital disorders of glycosylation (CDG): quo vadis? Eur J Med Genet. 2017 Oct 25. doi:10.1016/j.ejmg.2017.10.012.
- Al-Gazali L, Hertecant J, Algawi K, El Teraifi H, Dattani M. A new autosomal recessive syndrome of ocular colobomas, ichthyosis, brain malformations and endocrine abnormalities in an inbred Emirati family. Am J Med Genet A. 2008 Apr 1;146A(7):813–19. doi:10.1002/ajmg.a.32114.
- Cantagrel V, Lefeber DJ, Ng BG, Guan Z, Silhavy JL, Bielas SL, Lehle L, Hombauer H, Adamowicz M, Swiezewska E, et al. SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder. Cell. 2010 July 23;142(2):203–17. doi:10.1016/j.cell.2010.06.001.
- Prietsch V, Peters V, Hackler R, Jakobi R, Assmann B, Fang J, Körner C, Helwig-Rolig A, Schaefer JR, Hoffmann GF. A new case of CDG-x with stereotyped dystonic hand movements and optic atrophy. J Inherit Metab Dis. 2002 May;25(2):126–30. doi:10.1023/A:1015628810892.
- Kahrizi K, Hu CH, Garshasbi M, Abedini SS, Ghadami S, Kariminejad R, Campbell M, Weinstock GM, Koboldt DC, Ding L, et al. Next generation sequencing in a family with autosomal recessive Kahrizi syndrome (OMIM 612713) reveals a homozygous frameshift mutation in SRD5A3. Eur J Hum Genet EJHG. 2011 Jan;19(1):115–17. doi:10.1038/ejhg.2011.86.
- Morava E, Wevers RA, Cantagrel V, Hoefsloot LH, Al-Gazali L, Schoots J, Van Rooij A, Huijben K, Van Ravenswaaij-Arts CMA, Jongmans MCJ, et al. A novel cerebello-ocular syndrome with abnormal glycosylation due to abnormalities in dolichol metabolism. Brain J Neurol. 2010 Nov;133(11):3210–20. doi:10.1093/brain/awq261.
- Gründahl JEH, Guan Z, Rust S, Reunert J, Müller B, Du Chesne I, Zerres K, Rudnik-Schöneborn S, Ortiz-Brüchle N, Häusler MG, et al. Life with too much polyprenol: polyprenol reductase deficiency. Mol Genet Metab. 2012 Apr;105(4):642–51. doi:10.1016/j.ymgme.2011.12.017.
- Assmann B, Hackler R, Peters V, Schaefer JR, Arndt T, Mayatepek E, Jaeken J, Hoffmann G. A new subtype of a congenital disorder of glycosylation (CDG) with mild clinical manifestations. Neuropediatrics. 2001 Dec;32(6):313–18. doi:10.1055/s-2001-20407.
- Kara B, Ayhan Ö, Gökçay G, Başboğaoğlu N, Tolun A. Adult phenotype and further phenotypic variability in SRD5A3-CDG. BMC Med Genet. 2014 Jan 16;15:10. doi:10.1186/s12881-014-0134-1.
- Taylor RL, Arno G, Poulter JA, Khan KN, Morarji J, Hull S, Pontikos N, Rueda Martin A, Smith KR, Ali M, et al. Association of Steroid 5α-Reductase Type 3 Congenital Disorder of Glycosylation With Early-Onset Retinal Dystrophy. JAMA Ophthalmol. 2017 Apr 1;135(4):339–47. doi:10.1001/jamaophthalmol.2017.0046.
- Wheeler PG, Ng BG, Sanford L, Sutton VR, Bartholomew DW, Pastore MT, Bamshad MJ, Kircher M, Buckingham KJ, Nickerson DA, et al. SRD5A3-CDG: expanding the phenotype of a congenital disorder of glycosylation with emphasis on adult onset features. Am J Med Genet A. 2016 Dec;170(12):3165–71. doi:10.1002/ajmg.a.v170.12.